Novigenix | Finanzwire

Basculer en Français

9551	Companies
188461	Keywords
120293	Articles
100630	Press releases

Home
Companies
Novigenix

PRESS RELEASE

published on 01/17/2024 at 08:00, 1 year 11 months ago

Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes.

Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care

Accesswire

Published on 12/18/2025 at 18:00, 30 minutes ago

PPX Mining Announces 2025 AGM Results
Published on 12/18/2025 at 15:00, 3 hours 30 minutes ago

Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 3 hours 59 minutes ago

Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 4 hours 30 minutes ago

Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 4 hours 30 minutes ago

LQR House Announces $6.52 Million Registered Direct Offering

View all ACCESSWIRE

EQS Group

Published on 12/18/2025 at 18:01, 29 minutes ago

POS-Transaction in Own Shares
Published on 12/18/2025 at 18:00, 30 minutes ago

Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland
Published on 12/18/2025 at 17:45, 45 minutes ago

ENOGIA: ENOGIA selected to supply South Korea’s first fully privately financed waste-heat-to-power project on a fuel cell plant
Published on 12/18/2025 at 17:40, 50 minutes ago

LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 30 november 2025.
Published on 12/18/2025 at 17:40, 50 minutes ago

VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance

Les Echos

Published on 12/18/2025 at 17:45, 45 minutes ago

Cie du Bois Sauvage : Cancellation of own shares
Published on 12/18/2025 at 16:31, 1 hour 59 minutes ago

In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide
Published on 12/17/2025 at 20:39, 21 hours 51 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 19:30, 23 hours ago

Change in the composition of the Board
Published on 12/17/2025 at 18:00, 1 day ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE